Menu
GWAS Study

Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer.

Xu HM, Han Y, Liu ZC et al.

38809553 PubMed ID
GWAS Study Type
2816 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

XH
Xu HM
HY
Han Y
LZ
Liu ZC
YZ
Yin ZY
WM
Wang MY
YC
Yu C
MJ
Ma JL
SD
Sun D
LW
Liu WD
ZY
Zhang Y
ZT
Zhou T
ZJ
Zhang JY
PP
Pei P
YL
Yang L
MI
Millwood IY
WR
Walters RG
CY
Chen Y
DH
Du H
CZ
Chen Z
YW
You WC
LL
Li L
PK
Pan KF
LJ
Lv J
LW
Li WQ
Chapter II

Abstract

Summary of the research findings

Importance: Helicobacter pylori treatment and nutrition supplementation may protect against gastric cancer (GC), but whether the beneficial effects only apply to potential genetic subgroups and whether high genetic risk may be counteracted by these chemoprevention strategies remains unknown.

2,816 East Asian ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

2816
Total Participants
GWAS
Study Type
No
Replicated
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.